Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch

Concetta Rafaniello(University of Campania "Luigi Vanvitelli"), Annalisa Capuano(Regione Campania), Carla Carnovale(Luigi Sacco Hospital), Carmela Bravaccio(Federico II University Hospital), Sonia Radice(Luigi Sacco Hospital), Serena Sperandeo(University of Campania "Luigi Vanvitelli"), Laura Villa(IRCCS Eugenio Medea), Elisa Mani(IRCCS Eugenio Medea), Carmen Ferrajolo(University of Campania "Luigi Vanvitelli"), Maria Pia Riccio(University of Campania "Luigi Vanvitelli"), Simone Pisano(University of Campania "Luigi Vanvitelli"), Marco Pozzi(IRCCS Eugenio Medea), Massimo Molteni(IRCCS Eugenio Medea), Renato Bernardini(University of Catania), Maria Giuseppa Sullo(University of Campania "Luigi Vanvitelli"), Marta Gentili(Luigi Sacco Hospital), Antonio Pascotto(University of Campania "Luigi Vanvitelli"), Silvana Bertella(IRCCS Eugenio Medea), Dario Cattaneo(ASST Fatebenefratelli Sacco), Liberata Sportiello(University of Campania "Luigi Vanvitelli"), Renata Rizzo(University of Catania), Francesco Rossi(Agostino Gemelli University Polyclinic), Emilio Clementi(Luigi Sacco Hospital)
Expert Opinion on Drug Safety
November 22, 2016
Cited by 33


Related Papers